In addition, the analysis of TGFBR2 expression in patients diagnosed with ES (n = 117) using GSE34620 showed that TGFBR2 was markedly decreased in patients with high TrkC expression than in those with relatively low TrkC expression (Fig. S9). This evidence concerns the gene TGFBR2 and Ewing sarcoma.